Bioeden
BioEden is a UK-based biotechnology company offering direct-to-consumer banking of mesenchymal stem cells extracted from children's milk teeth, providing cryogenic storage and private family access under the Future Health Biobank brand.
- Company typePrivate
- Founded2006
- HeadquartersNottingham, United Kingdom
- Headcount11–50
- GTM typeB2C
- OfferingServices
Bioeden firmographics
Firmographics- Name
- Bioeden
- Legal name
- BioEden
- Website
- https://bioeden.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BioEden is a UK-based biotechnology company offering direct-to-consumer banking of mesenchymal stem cells extracted from children's milk teeth, providing cryogenic storage and private family access under the Future Health Biobank brand.
- Ownership category
- akta.pro rank
Bioeden industry classification
Industry- Product category
- Stem Cell Banking Services
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC) (HLAMANAJ)
- akta.pro secondary industries
- Infant Oral Health & Early Childhood Caries Programs (HLABAGAH), Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ)
Keywords
Where Bioeden is headquartered
LocationHeadquarters
- HQ city
- Nottingham
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Bioeden business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Tooth Stem Cell Banking Service: One-time collection fee plus ongoing annual storage fees for cryogenic preservation of dental pulp stem cells. Samples stored privately for exclusive family access.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Dental Pulp Banking Service |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Bioeden product offering
Product offeringCore offering
BioEden collects children's naturally exfoliated milk teeth and processes them to extract and cryogenically store mesenchymal stem cells (MSCs) for potential future medical treatments. The service includes provision of a tooth collection kit, laboratory processing of dental pulp, and long-term private cryogenic storage accessible only to the child and family members. Customers make a one-time collection payment plus recurring annual storage fees, with payments processed via Stripe in USD or GBP.
Product overview
BioEden is a dental pulp stem cell banking service that collects, processes, and cryogenically stores mesenchymal stem cells from children's milk teeth. The company operates as part of Future Health Biobank and offers tooth stem cell collection kits, laboratory processing, and long-term cryogenic storage services. Customers can store samples privately for family access, with payment processing handled through Stripe. The service also provides a customer care team offering support in English and Spanish, and maintains a UK headquarters in Nottingham.
Differentiator
Problem solved
Functional benefit
Products and services
- Dental Pulp Banking (Tooth Stem Cell Banking) BioEden's primary service for collecting, processing, and cryogenically storing mesenchymal stem cells (MSCs) extracted from children's fallen milk teeth. Samples are stored privately for exclusive access by the child and family members, intended for potential future medical treatments.
Quantifiable outcome
- Successfully thawed, cultured and differentiated tooth cells cryopreserved in 2012
Companies that use Bioeden
Customer profileSegments1 record
Ideal customer profiles1 record
Bioeden technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Bioeden partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Future Health GroupcoreFuture Health Group acquired BioEden and now operates BioEden as a brand under its Future Health Biobank umbrella. Customer care is handled through Future Health headquarters in Nottingham, UK. The acquisition enables combined service offerings including umbilical cord banking and dental pulp banking.
Scale indicators2 records
Recent moves7 records
Expansion highlights4 records
Bioeden competitors and assessment
Company assessmentDirect peers
- Store-A-Tooth: Tooth stem cell banking service (now part of Provia Labs) that provides dental pulp MSC collection and cryopreservation. Directly comparable to BioEden in product, target customer (parents), and storage-based recurring revenue model.
- Precious Cells International: UK-based stem cell bank offering cord blood, cord tissue, and placental tissue storage. Comparable in geographic focus (UK), HTA regulatory footprint, and recurring-storage revenue model targeting expectant parents.
- Smart Cells International: UK-based stem cell bank specializing in umbilical cord blood and tissue storage. Highly comparable geography (UK), target customer (expectant parents), and recurring-storage business model; directly competes for the same Future Health customer base.
- StemSave: US-based dental stem cell banking service that collects and cryopreserves mesenchymal stem cells from extracted teeth. Most direct competitor to BioEden globally, offering essentially the same product (MSC banking from teeth) to a parental customer base.
- Cells4Life: UK-based cord blood and tissue stem cell bank with strong NHS/private hospital partnerships. Closest UK-based direct competitor to BioEden's parent (Future Health), with comparable customer base and HTA-licensed operating model.
Broad incumbents
- ViaCord: US cord blood and cord tissue bank owned by Revvity (formerly PerkinElmer). Comparable recurring-revenue stem cell banking model targeting expectant and new parents; relevant benchmark for clinical positioning and storage pricing.
- Future Health Biobank: Parent company of BioEden, offering umbilical cord blood banking, dental pulp banking, NIPT, and genetic screening. Operates BioEden as a sub-brand and is the most strategically comparable UK-based stem cell bank with a wider service portfolio.
- StemCyte: Global cord blood banking operator with public cord blood inventory and private storage services. Comparable recurring-revenue model and parent-targeted marketing, with deeper therapeutic-research positioning than BioEden.
- Cryo-Cell International: US-listed public stem cell banking company offering cord blood and cord tissue banking plus menstrual stem cell services. Comparable business model (one-time fee plus annual storage) and overlapping target demographic of parents.
- Cord Blood Registry (CBR): Largest US cord blood stem cell bank, now part of the California Cryobank family. Comparable as a recurring-revenue pediatric stem cell storage business targeting expectant parents; many customers view cord blood and dental pulp as substitute products.
Market position
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Bioeden social profiles
Digital presenceBioeden compliance and trust
Trust signalCompliance8 records
Bioeden financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bioeden leadership team
Management profileNumber of profiles
Profiles1 record
Bioeden funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bioeden M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bioeden
What does Bioeden do?
BioEden collects children's naturally exfoliated milk teeth and processes them to extract and cryogenically store mesenchymal stem cells (MSCs) for potential future medical treatments. The service includes provision of a tooth collection kit, laboratory processing of dental pulp, and long-term private cryogenic storage accessible only to the child and family members. Customers make a one-time collection payment plus recurring annual storage fees, with payments processed via Stripe in USD or GBP.
Is Bioeden a public or private company?
Bioeden is a private company. It is classified as corporate owned and is currently operating.
When was Bioeden founded?
Bioeden was founded in 2006. It employs 11 to 50 people.
Where is Bioeden based?
Bioeden is headquartered in Nottingham, United Kingdom, in the Europe region.
How does Bioeden make money?
One revenue line is on record: tooth Stem Cell Banking Service.
Who are Bioeden's main competitors?
Direct peers on record are Store-A-Tooth, Precious Cells International, Smart Cells International, StemSave and Cells4Life. Broad incumbents are ViaCord, Future Health Biobank, StemCyte, Cryo-Cell International and Cord Blood Registry (CBR).
Does Bioeden have an API?
No public API is recorded for Bioeden.
What industry is Bioeden in?
Bioeden's product category is Stem Cell Banking Services. Its primary akta.pro industry code is HLAMANAJ, Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC), with a secondary code of HLABAGAH, Infant Oral Health & Early Childhood Caries Programs. Its NAICS code is 621991 and its SIC code is 2836.